{"id":4443941339187,"title":"Nobivac Canine 1-DAPPv 25x1","handle":"nobivac-canine-1-dappv","description":"A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus. \u003c!-- split --\u003e \u003c!-- TABS --\u003e\n\u003ch5\u003eDescription\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eProtects against all known strains of CPV, including CPV-2c\u003c\/li\u003e\n\u003cli\u003eHigh antigenic mass (titer), low passage parvovirus vaccine\u003c\/li\u003e\n\u003cli\u003eCanine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus\u003c\/li\u003e\n\u003cli\u003eProtects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs\u003c\/li\u003e\n\u003cli\u003eProvides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula\u003c\/li\u003e\n\u003cli\u003eFirst to publish data showing protection against CPV-2c challenge\u003c\/li\u003e\n\u003cli\u003eMultiple studies demonstrate the ability to override maternal antibodies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003eIndications\u003cbr\u003e\n\u003c\/h5\u003e\n\u003cp\u003e\u003cspan\u003eAn aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.\u003c\/span\u003e\u003cspan class=\"break-line\"\u003eRecommended for use in healthy dogs 6 weeks of age or older.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch5\u003eAdministration and Dosage\u003cbr\u003e\n\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eSubcutaneous or intramuscular injection\u003c\/li\u003e\n\u003cli\u003ePrimary vaccination may begin as early as 6 weeks\u003c\/li\u003e\n\u003cli\u003eRepeat at 2 to 4 week intervals until the dog is 12 weeks of age\u003c\/li\u003e\n\u003cli\u003eAnnual revaccination with 1 dose is recommended\u003c\/li\u003e\n\u003cli\u003eAvailable in a 25 x 1 mL dose presentation\u003c\/li\u003e\n\u003c\/ul\u003e","published_at":"2020-02-07T13:17:39-06:00","created_at":"2020-02-07T13:48:27-06:00","vendor":"Nobivac","type":"","tags":["BRAND_Nobivac","MENU_VeterinarySupplies","TYPE_Vaccine"],"price":0,"price_min":0,"price_max":0,"available":true,"price_varies":false,"compare_at_price":null,"compare_at_price_min":0,"compare_at_price_max":0,"compare_at_price_varies":false,"variants":[{"id":31611200733235,"title":"Default Title","option1":"Default Title","option2":null,"option3":null,"sku":"","requires_shipping":true,"taxable":true,"featured_image":null,"available":true,"name":"Nobivac Canine 1-DAPPv 25x1","public_title":null,"options":["Default Title"],"price":0,"weight":0,"compare_at_price":null,"inventory_management":null,"barcode":""}],"images":["\/\/cdn.shopify.com\/s\/files\/1\/0186\/9306\/2707\/products\/nobivac_DAPPv.png?v=1581104907"],"featured_image":"\/\/cdn.shopify.com\/s\/files\/1\/0186\/9306\/2707\/products\/nobivac_DAPPv.png?v=1581104907","options":["Title"],"media":[{"alt":null,"id":6054138806323,"position":1,"preview_image":{"aspect_ratio":1.5,"height":576,"width":864,"src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0186\/9306\/2707\/products\/nobivac_DAPPv.png?v=1581104907"},"aspect_ratio":1.5,"height":576,"media_type":"image","src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0186\/9306\/2707\/products\/nobivac_DAPPv.png?v=1581104907","width":864}],"content":"A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus. \u003c!-- split --\u003e \u003c!-- TABS --\u003e\n\u003ch5\u003eDescription\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eProtects against all known strains of CPV, including CPV-2c\u003c\/li\u003e\n\u003cli\u003eHigh antigenic mass (titer), low passage parvovirus vaccine\u003c\/li\u003e\n\u003cli\u003eCanine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus\u003c\/li\u003e\n\u003cli\u003eProtects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs\u003c\/li\u003e\n\u003cli\u003eProvides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula\u003c\/li\u003e\n\u003cli\u003eFirst to publish data showing protection against CPV-2c challenge\u003c\/li\u003e\n\u003cli\u003eMultiple studies demonstrate the ability to override maternal antibodies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003eIndications\u003cbr\u003e\n\u003c\/h5\u003e\n\u003cp\u003e\u003cspan\u003eAn aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.\u003c\/span\u003e\u003cspan class=\"break-line\"\u003eRecommended for use in healthy dogs 6 weeks of age or older.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch5\u003eAdministration and Dosage\u003cbr\u003e\n\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eSubcutaneous or intramuscular injection\u003c\/li\u003e\n\u003cli\u003ePrimary vaccination may begin as early as 6 weeks\u003c\/li\u003e\n\u003cli\u003eRepeat at 2 to 4 week intervals until the dog is 12 weeks of age\u003c\/li\u003e\n\u003cli\u003eAnnual revaccination with 1 dose is recommended\u003c\/li\u003e\n\u003cli\u003eAvailable in a 25 x 1 mL dose presentation\u003c\/li\u003e\n\u003c\/ul\u003e"}

Nobivac Canine 1-DAPPv 25x1

Product Description
A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus.
Call for Price
Maximum quantity available reached.
  • Protects against all known strains of CPV, including CPV-2c
  • High antigenic mass (titer), low passage parvovirus vaccine
  • Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus
  • Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
  • Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula
  • First to publish data showing protection against CPV-2c challenge
  • Multiple studies demonstrate the ability to override maternal antibodies

An aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.Recommended for use in healthy dogs 6 weeks of age or older.

  • Subcutaneous or intramuscular injection
  • Primary vaccination may begin as early as 6 weeks
  • Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1 mL dose presentation

Related products